Balyasny Asset Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-15,419
| Closed | -$2.12M | – | 1999 |
|
|
2024
Q4 | $2.12M | Buy |
+15,419
| New | +$2.12M | ﹤0.01% | 1089 |
|
|
2024
Q3 | – | Sell |
-4,221
| Closed | -$576K | – | 1945 |
|
|
2024
Q2 | $576K | Buy |
+4,221
| New | +$576K | ﹤0.01% | 1413 |
|
|
2023
Q4 | – | Sell |
-94,868
| Closed | -$8.88M | – | 1908 |
|
|
2023
Q3 | $8.88M | Buy |
+94,868
| New | +$8.88M | 0.02% | 645 |
|
|
2023
Q2 | – | Sell |
-13,394
| Closed | -$1.44M | – | 1849 |
|
|
2023
Q1 | $1.44M | Sell |
13,394
-40,103
| -75% | -$4.3M | ﹤0.01% | 1219 |
|
|
2022
Q4 | $6.53M | Buy |
+53,497
| New | +$6.53M | 0.02% | 685 |
|